**Core Concept**
Sickle cell anemia is a genetic disorder caused by a point mutation in the HBB gene, leading to the production of abnormal hemoglobin (HbS) that polymerizes and forms sickle-shaped erythrocytes under deoxygenated conditions. This results in hemolytic anemia, vaso-occlusive crises, and increased susceptibility to infections.

**Why the Correct Answer is Right**
The polymerization of HbS is facilitated by dehydration and denaturation of the hemoglobin molecule, which reduces the solubility of the abnormal hemoglobin. This process is favored by low oxygen tension, increased concentration of HbS, and increased temperature. The polymerization of HbS leads to the formation of rigid fibers that distort the erythrocyte into a sickle shape, causing vaso-occlusion and tissue ischemia. The HbS molecule adheres to endothelial cells, platelets, and other RBCs, leading to increased blood viscosity and further exacerbating vaso-occlusion.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe the pathogenesis of sickle cell anemia. While oxidative stress and inflammation play roles in the disease process, they are not the primary cause of the sickling phenomenon.
**Option B:** This option is incorrect as it misidentifies the genetic defect responsible for sickle cell anemia. The mutation occurs in the HBB gene, not the HBA1 or HBA2 genes that encode alpha-globin.
**Option C:** This option is incorrect as it does not accurately describe the primary mechanism of vaso-occlusion in sickle cell anemia. While endothelial dysfunction and platelet activation contribute to the disease process, they are not the primary cause of vaso-occlusion.

**Clinical Pearl / High-Yield Fact**
It is essential to note that sickle cell anemia is a prototype for the understanding of the relationship between genetics, molecular biology, and clinical disease. The discovery of the HBB gene mutation responsible for sickle cell anemia marked a significant milestone in the field of molecular medicine and highlights the importance of understanding the genetic basis of disease in the development of targeted therapies.

**Correct Answer:** None of the above options accurately describe the pathogenesis of sickle cell anemia.